Publication Cover
LEUKOS
The Journal of the Illuminating Engineering Society
Volume 19, 2023 - Issue 3
882
Views
3
CrossRef citations to date
0
Altmetric
Articles

Photoreceptor Enhanced Light Therapy (PELT): A Framework for Implementing BiologicallyDirected Integrative Lighting

ORCID Icon, & ORCID Icon
Pages 294-307 | Received 08 Jun 2022, Accepted 08 Sep 2022, Published online: 24 Oct 2022

References

  • Adhikari P, Feigl B, Zele AJ. 2016a. Rhodopsin and melanopsin contributions to the early redilation phase of the Post-Illumination Pupil Response (PIPR). PLoS One. 11(8):e0161175.
  • Adhikari P, Pearson CA, Anderson AM, Zele AJ, Feigl B. 2015. Effect of age and refractive error on the melanopsin mediated Post-Illumination Pupil Response (PIPR). Sci Rep. 5(1):17610.
  • Adhikari P, Pradhan A, Zele AJ, Feigl B. 2021. Supplemental light exposure improves sleep architecture in people with type 2 diabetes. Acta Diabetol. 58(9):1201–1208.
  • Adhikari P, Zele AJ, Thomas R, Feigl B. 2016b. Quadrant field pupillometry detects melanopsin dysfunction in glaucoma suspects and early glaucoma. Sci Rep. 6(1):33373.
  • Altimus CM, Guler AD, Alam NM, Arman AC, Prusky GT, Sampath AP, Hattar S. 2010. Rod photoreceptors drive circadian photoentrainment across a wide range of light intensities. Nat Neurosci. 13(9):1107–1112.
  • Arendt J. 2010. Shift work: coping with the biological clock. Occup Med (London). 60(1):10–20.
  • Auffret E, Gomart G, Bourcier T, Gaucher D, Speeg-Schatz C, Sauer A. 2021. Digital eye strain. Symptoms, prevalence, pathophysiology, and management. J Fr Ophtalmol. 44(10):1605–1610.
  • Barrionuevo PA, Nicandro N, McAnany JJ, Zele AJ, Gamlin P, Cao D. 2014. Assessing rod, cone, and melanopsin contributions to human pupil flicker responses. Invest Ophthalmol Vis Sci. 55(2):719–727.
  • Bayer FS, Paulun VC, Weiss D, Gegenfurtner KR. 2015. A tetrachromatic display for the spatiotemporal control of rod and cone stimulation. J Vis. 15(11):15.
  • Bearse MA Jr., Adams AJ, Han Y, Schneck ME, Ng J, Bronson-Castain K, Barez S. 2006. A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res. 25(5):425–448.
  • Berson DM, Dunn FA, Takao M. 2002. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 295(5557):1070–1073.
  • Besenecker UC, Bullough JD, Radetsky LC. 2016. Spectral sensitivity and scene brightness at low to moderate photopic light levels. Light Res Tech. 48(6):676–688.
  • Bosten JM, Beer RD, MacLeod DI. 2015. What is white? J Vis. 15(16):5.
  • Burgos FJ, Vilaseca M, Perales E, Herrera-Ramirez JA, Martinez-Verdu FM, Pujol J. 2014. Spectral LED-based tunable light source for the reconstruction of CIE standard illuminants. Image and Signal Processing ICISP 2014; Cherbourg, France: Springer International Publishing.
  • Cajochen C. 2007. Alerting effects of light. Sleep Med Rev. 11(6):453–464.
  • Cao D, Pokorny J, Smith VC, Zele AJ. 2008. Rod contributions to color perception: linear with rod contrast. Vision Res. 48(26):2586–2592.
  • Chew I, Kalavally V, Tan CP, Parkkinen J. 2016. A spectrally tunable smart led lighting system with closed-loop control. IEEE Sens J. 16(11):4452–4459.
  • Chougule PS, Najjar RP, Finkelstein MT, Kandiah N, Milea D. 2019. Light-induced pupillary responses in Alzheimer’s disease. Front Neurol. 10.
  • Czeisler CA, Kronauer RE, Allan JS, Duffy JF, Jewett ME, Brown EN, Ronda JM. 1989. Bright light induction of strong (type 0) resetting of the human circadian pacemaker. Science. 244(4910):1328–1333.
  • Dijk DJ, Duffy JF, Czeisler CA. 1992. Circadian and sleep/wake dependent aspects of subjective alertness and cognitive performance. J Sleep Res. 1(2):112–117.
  • Dimitrov PN, Guymer RH, Zele AJ, Anderson AJ, Vingrys AJ. 2008. Measuring rod and cone dynamics in age-related maculopathy. Invest Ophthalmol Vis Sci. 49(1):55–65.
  • Dumpala S, Zele AJ, Feigl B. 2019. Outer retinal structure and function deficits contribute to circadian disruption in patients with type 2 diabetes. Invest Ophthalmol Vis Sci. 60(6):1870–1878.
  • Enezi J, Revell V, Brown T, Wynne J, Schlangen L, Lucas R. 2011. A “melanopic” spectral efficiency function predicts the sensitivity of melanopsin photoreceptors to polychromatic lights. J Biol Rhythms. 26(4):314–323.
  • Farràs AL. 2019. Spectral control methods and applications for multi-channel LED light engines [dissertation]. Barcelona (Spain): Universitat Politècnica de Catalunya.
  • Feigl B, Brown B, Lovie-Kitchin J, Swann P. 2005. Adaptation responses in early age-related maculopathy. Invest Ophthalmol Vis Sci. 46(12):4722–4727.
  • Feigl B, Dumpala S, Kerr GK, Zele AJ. 2020. Melanopsin cell dysfunction is involved in sleep disruption in Parkinson’s disease. J Parkinsons Dis. 10(4):1467–1476.
  • Feigl B, Mattes D, Thomas R, Zele AJ. 2011. Intrinsically photosensitive (melanopsin) retinal ganglion cell function in glaucoma. Invest Ophthalmol Vis Sci. 52(7):4362–4367.
  • Feigl B, Morris CP, Brown B, Zele AJ. 2012a. Relationship among CFH and ARMS2 genotypes, macular pigment optical density, and neuroretinal function in persons without age-related macular degeneration. Arch Ophthalmol. 130(11):1402–1409.
  • Feigl B, Ojha G, Hides L, Zele AJ. 2018. Melanopsin-driven pupil response and light exposure in non-seasonal major depressive disorder. Front Neurol. 9:764.
  • Feigl B, Zele AJ. 2014. Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease. Optom Vis Sci. 91(8):894–903.
  • Feigl B, Zele AJ, Fader SM, Howes AN, Hughes CE, Jones KA, Jones R. 2012b. The post-illumination pupil response of melanopsin-expressing intrinsically photosensitive retinal ganglion cells in diabetes. Acta Ophthalmol. 90(3):e230–234.
  • Figueiro MG, Plitnick B, Rea MS. 2016. Research note: a self-luminous light table for persons with Alzheimer’s disease. Lighting Res Technol. 48(2):253–259.
  • Fryc I, Brown D, Ohni Y. 2005. Spectral matching with an LED-based spectrally tunable light source. Proc SPIE. 59411:59411I.
  • Gooley JJ. 2008. Treatment of circadian rhythm sleep disorders with light. Ann Acad Med Singap. 37(8):669–676. https://www.ncbi.nlm.nih.gov/pubmed/18797560
  • Gordo MA, Recio J, Sanchez-Barcelo EJ. 2001. Decreased sleep quality in patients suffering from retinitis pigmentosa. J Sleep Res. 10(2):159–164.
  • Gracitelli CPB, Paranhos Jr. A. 2015. Can glaucoma affect sleep quality? Arq Bras Oftalmol. 78(3):V–Vi.
  • Hirakawa H, Terao T, Muronaga M, Ishii N. 2020. Adjunctive bright light therapy for treating bipolar depression: a systematic review and meta-analysis of randomized controlled trials. Brain Behav. 10(12):e01876.
  • Houser KW, Boyce PR, Zeitzer JM, Herf M. 2021. Human-centric lighting: myth, magic or metaphor? Lighting Res Technol. 53(2):97–118.
  • Joines S, James T, Liu SW, Wang WJ, Dunn R, Cohen S. 2015. Adjustable task lighting: field study assesses the benefits in an office environment. Work. 51(3):471–481.
  • Joyce DS, Feigl B, Kerr G, Roeder L, Zele AJ. 2018. Melanopsin-mediated pupil function is impaired in Parkinson’s disease. Sci Rep. 8(1):7796.
  • Judd DB, Macadam DL, Wyszecki G. 1964. Spectral distribution of typical daylight as function of correlated color temperature. J Opt Soc Am. 54(8):1031–1040.
  • Kawasaki A, Kardon RH. 2007. Intrinsically photosensitive retinal ganglion cells. J Neuroophthalmol. 27(3):195–204.
  • Kelbsch C, Strasser T, Chen Y, Feigl B, Gamlin PD, Kardon R, Peters T, Roecklein KA, Steinhauer SR, Szabadi E, et al. 2019. Standards in pupillography. Front Neurol. 10:129.
  • Khurana RN, Porco TC, Claman DM, Boldrey EE, Palmer JD, Wieland MR. 2016. Increasing sleep duration is associated with geographic atrophy and age-related macular degeneration. Retina. 36(2):255–258.
  • Killgore WDS, Vanuk JR, Shane BR, Weber M, Bajaj S. 2020. A randomized, double-blind, placebo-controlled trial of blue wavelength light exposure on sleep and recovery of brain structure, function, and cognition following mild traumatic brain injury. Neurobiol Dis. 134:104679.
  • Kolberg D, Schubert F, Lontke N, Zwigart A, Spinner DM. 2011. Development of tunable close match LED solar simulator with extended spectral range to UV and IR. Energy Procedia. 8:100–105.
  • Lamb TD, Pugh EN Jr. 2006. Phototransduction, dark adaptation, and rhodopsin regeneration the proctor lecture. Invest Ophthalmol Vis Sci. 47(12):5137–5152.
  • La Morgia C, Carelli V, Carbonelli M. 2018. Melanopsin retinal ganglion cells and pupil: clinical implications for neuro-ophthalmology. Front Neurol. 9:1047.
  • La Morgia C, Ross-Cisneros FN, Koronyo Y, Hannibal J, Gallassi R, Cantalupo G, Sambati L, Pan BX, Tozer KR, Barboni P, et al. 2016. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol. 79(1):90–109.
  • Lieverse R, Van Someren EJ, Nielen MM, Uitdehaag BM, Smit JH, Hoogendijk WJ. 2011. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry. 68(1):61–70.
  • Llenas A, Carreras J. 2019a. Arbitrary spectral matching using multi-LED lighting systems. Opt Eng. 58(3):1.
  • Llenas A, Carreras J. 2019b. A simple yet counterintuitive optical feedback controller for spectrally tunable lighting systems. Opt Eng. 58(3):1.
  • MacLeod DI, Boynton RM. 1979. Chromaticity diagram showing cone excitation by stimuli of equal luminance. J Opt Soc Am. 69(8):1183–1186.
  • Marc RE, Jones BW, Watt CB, Strettoi E. 2003. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 22(5):607–655.
  • Markwell EL, Feigl B, Zele AJ. 2010. Intrinsically photosensitive melanopsin retinal ganglion cell contributions to the pupillary light reflex and circadian rhythm. Clin Exp Optom. 93(3):137–149.
  • Marshall J. 2016. Light in man’s environment. Eye (London). 30(2):211–214.
  • Maynard ML, Zele AJ, Feigl B. 2015. Melanopsin-mediated post-illumination pupil response in early age-related macular degeneration. Invest Ophthalmol Vis Sci. 56(11):6906–6913.
  • Maynard ML, Zele AJ, Kwan AS, Feigl B. 2017. Intrinsically photosensitive retinal ganglion cell function, sleep efficiency and depression in advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 58(2):990–996.
  • Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, Koutsandrea C. 2011. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol. 21(1):24–29.
  • Munch M, Scheuermaier KD, Zhang R, Dunne SP, Guzik AM, Silva EJ, Ronda JM, Duffy JF. 2011. Effects on subjective and objective alertness and sleep in response to evening light exposure in older subjects. Behav Brain Res. 224(2):272–278.
  • Ortuño-Lizarán I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P, Cuenca N. 2018. Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease. Acta Neuropathol Commun 10;6(1):90.
  • Park JC, Chen YF, Blair NP, Chau FY, Lim JI, Leiderman YI, Shahidi M, McAnany JJ. 2017. Pupillary responses in non-proliferative diabetic retinopathy. Sci Rep. 7(1):44987.
  • Roecklein K, Wong P, Ernecoff N, Miller M, Donofry S, Kamarck M, Wood-Vasey WM, Franzen P. 2013a. The post illumination pupil response is reduced in seasonal affective disorder. Psychiatry Res. 210(1):150–158.
  • Roecklein KA, Wong PM, Miller MA, Donofry SD, Kamarck ML, Brainard GC. 2013b. Melanopsin, photosensitive ganglion cells, and seasonal affective disorder. Neurosci Biobehav Rev. 37(3):229–239.
  • Romagnoli M, Stanzani Maserati M, De Matteis M, Capellari S, Carbonelli M, Amore G, Cantalupo G, Zenesini C, Liguori R, Sadun AA, et al. 2020. Chromatic pupillometry findings in Alzheimer’s disease. Front Neurosci. 14:780.
  • Ruger M, Scheer FA. 2009. Effects of circadian disruption on the cardiometabolic system. Rev Endocr Metab Disord. 10(4):245–260.
  • Shekleton JA, Flynn-Evans EE, Miller B, Epstein LJ, Kirsch D, Brogna LA, Burke LM, Bremer E, Murray JM, Gehrman P, et al. 2014. Neurobehavioral performance impairment in insomnia: relationships with self-reported sleep and daytime functioning. Sleep. 37(1):107–U324.
  • Skomro RP, Ludwig S, Salamon E, Kryger MH. 2001. Sleep complaints and restless legs syndrome in adult type 2 diabetics. Sleep Med. 2(5):417–422.
  • Smith VC, Pokorny J. 1975. Spectral sensitivity of the foveal cone photopigments between 400 and 500 nm. Vision Res. 15(2):161–171.
  • Tanaka H, Ishida K, Ozawa K, Ishihara T, Sawada A, Mochizuki K, Yamamoto T. 2021. Relationship between structural and functional changes in glaucomatous eyes: a multifocal electroretinogram study. BMC Ophthalmol. 21(1):305.
  • Terman M, Terman JS. 2005. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 10(8):647–663. quiz 672 doi:10.1017/s1092852900019611.
  • Tuunainen A, Kripke DF, Endo T. 2004. Light therapy for non-seasonal depression. Cochrane Database Syst Rev. (2):CD004050. doi:10.1002/14651858.CD004050.pub2.
  • Uddin MS, Tewari D, Mamun AA, Kabir MT, Niaz K, Wahed MII, Barreto GE, Ashraf GM. 2020. Circadian and sleep dysfunction in Alzheimer’s disease. Ageing Res Rev. 60:101046.
  • Uprety S, Adhikari P, Feigl B, Zele AJ. 2022. Melanopsin photoreception differentially modulates rod-mediated and cone-mediated human temporal vision. iScience. 25(7):104529.
  • Uprety S, Zele AJ, Feigl B, Cao D, Adhikari P. 2021. Optimizing methods to isolate melanopsin-directed responses. J Opt Soc Am A Opt Image Sci Vis. 38(7):1051–1064.
  • Videnovic A, Willis GL. 2016. Circadian system - a novel diagnostic and therapeutic target in Parkinson’s disease? Mov Disord. 31(3):260–269.
  • Wang H, Zhang Y, Ding J, Wang N. 2013. Changes in the circadian rhythm in patients with primary glaucoma. PLoS One. 8(4):e62841.
  • Webster MA. 2020. The verriest lecture: adventures in blue and yellow. J Opt Soc Am A. 37(4):V1–V14.
  • Zele AJ, Adhikari P, Cao D, Feigl B. 2019. Melanopsin driven enhancement of cone-mediated visual processing. Vision Res. 160:72–81.
  • Zele AJ, Adhikari P, Feigl B, Cao D. 2018a. Cone and melanopsin contributions to human brightness estimation. J Opt Soc Am A. 35(4):B19–B25.
  • Zele AJ, Cao D. 2015. Vision under mesopic and scotopic illumination. Front Psychol. 5:1594.
  • Zele AJ, Dey A, Adhikari P, Feigl B. 2020. Rhodopsin and melanopsin contributions to human brightness estimation. J Opt Soc Am A. 37(4):A145–A153.
  • Zele AJ, Dey A, Adhikari P, Feigl B. 2021. Melanopsin hypersensitivity dominates interictal photophobia in migraine. Cephalalgia. 41(2):217–226.
  • Zele AJ, Feigl B, Adhikari P, Maynard ML, Cao D. 2018b. Melanopsin photoreception contributes to human visual detection, temporal and colour processing. Sci Rep. 8(1):3842.
  • Zele AJ, Feigl B, Carter DD, inventors; Queensland University of Technology (QUT). 2022May12. Device, method, and system for biologically balanced lighting. World Intellectual Property Organization. Patent Cooperation Treaty. WO2022/094678A1.
  • Zele AJ, Gamlin PD. 2020. Editorial: The pupil: behavior, anatomy, physiology and clinical biomarkers. Front Neurol. 11:211.